These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30240951)

  • 1. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
    Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
    Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Activities of Natural and Synthetic Peptides.
    Hilchie AL; Hoskin DW; Power Coombs MR
    Adv Exp Med Biol; 2019; 1117():131-147. PubMed ID: 30980357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer β-hairpin peptides: membrane-induced folding triggers activity.
    Sinthuvanich C; Veiga AS; Gupta K; Gaspar D; Blumenthal R; Schneider JP
    J Am Chem Soc; 2012 Apr; 134(14):6210-7. PubMed ID: 22413859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
    Huang Y; Feng Q; Yan Q; Hao X; Chen Y
    Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
    Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of anticancer peptides (ACPs) from amphibian origin.
    Oelkrug C; Hartke M; Schubert A
    Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides.
    Zhao Y; Wang S; Fei W; Feng Y; Shen L; Yang X; Wang M; Wu M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).
    Chiangjong W; Chutipongtanate S; Hongeng S
    Int J Oncol; 2020 Sep; 57(3):678-696. PubMed ID: 32705178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycan Alteration Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide.
    Ishikawa K; Medina SH; Schneider JP; Klar AJS
    Cell Chem Biol; 2017 Feb; 24(2):149-158. PubMed ID: 28089756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
    Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Guided Discovery of Non-Hemolytic Membrane Disruptive Anticancer Peptides.
    Zakharova E; Orsi M; Capecchi A; Reymond JL
    ChemMedChem; 2022 Sep; 17(17):e202200291. PubMed ID: 35880810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
    Dennison SR; Whittaker M; Harris F; Phoenix DA
    Curr Protein Pept Sci; 2006 Dec; 7(6):487-99. PubMed ID: 17168782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structural optimization of oncolytic peptide LTX-315.
    Song M; Liu Q; Yao JF; Wang YT; Ma YN; Xu H; Yu QY; Li Z; Du SS; Qi YK
    Bioorg Med Chem; 2024 Jun; 107():117760. PubMed ID: 38762978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Design of Biologically Active Anticancer Peptides and Their Interactions with Heterogeneous POPC/POPS Lipid Membranes.
    Singh M; Kumar V; Sikka K; Thakur R; Harioudh MK; Mishra DP; Ghosh JK; Siddiqi MI
    J Chem Inf Model; 2020 Jan; 60(1):332-341. PubMed ID: 31880450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
    Papo N; Shai Y
    Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers.
    Aronson MR; Dahl ES; Halle JA; Simonson AW; Gogal RA; Glick AB; Aird KM; Medina SH
    Cell Mol Bioeng; 2020 Oct; 13(5):447-461. PubMed ID: 33184577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric cationic liposomes designed for heat-activated association with cells.
    Jing Y; Danielsson A; Trefná HD; Persson M; Svedhem S
    Colloids Surf B Biointerfaces; 2017 Mar; 151():112-118. PubMed ID: 27987456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.